Pages that link to "Q46528107"
Jump to navigation
Jump to search
The following pages link to Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy (Q46528107):
Displaying 13 items.
- Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations (Q28259237) (← links)
- Effects of antiepileptic drug monotherapy on one-carbon metabolism and DNA methylation in patients with epilepsy (Q28546720) (← links)
- Antiepileptic drugs and markers of vascular risk (Q34136014) (← links)
- One-carbon metabolism and bipolar disorder (Q34967290) (← links)
- Valproic acid in epilepsy : pregnancy-related issues (Q36384705) (← links)
- Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency (Q36952666) (← links)
- Age-related serum vitamin B12 concentrations in epileptic patients receiving valproate monotherapy (Q37311714) (← links)
- Lamotrigine decreased hippocampal damage and improved vascular risk markers in a rat model of pentylenetetrazole induced kindling seizure. (Q41197531) (← links)
- Effects of Common Anti-epileptic Drugs on the Serum Levels of Homocysteine and Folic Acid (Q42226983) (← links)
- Atherosclerotic effects of long-term old and new antiepileptic drugs monotherapy: a cross-sectional comparative study (Q46594751) (← links)
- Homocysteine levels in epileptic children receiving antiepileptic drugs (Q46823809) (← links)
- Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis (Q51365311) (← links)
- Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B(12), folate levels, and lipid profiles in epileptic children treated with valproic acid (Q51384965) (← links)